All Stories

  1. The Impact of Fabry Disease on Reproductive Fitness

    Article • January 2017, Springer Science + Business Media

    Eric W Hall, Mr Myrl D. Holida

  2. Detection of three families with GLA p.A143T mutation and low α-galactosidase levels by newborn screening for Fabry disease

    Article • Molecular Genetics and Metabolism, January 2017, Elsevier

    Mr Myrl D. Holida

  3. PRX-102 for treating Fabry disease: immunogenicity and PK results from a phase 1-2 study

    Article • Molecular Genetics and Metabolism, January 2017, Elsevier

    Mr Myrl D. Holida

  4. One-year follow up of Fabry disease patients treated by IV administration of a plant derived alpha-Gal-A enzyme: safety and efficacy

    Article • Molecular Genetics and Metabolism, January 2017, Elsevier

    Mr Myrl D. Holida

  5. The impact of Fabry disease on reproductive fitness

    Article • Molecular Genetics and Metabolism, February 2016, Elsevier

    Mr Myrl D. Holida

  6. Novel treatment for Fabry disease: IV administration of plant derived alpha-gal-A enzyme safety and efficacy interim report

    Article • Molecular Genetics and Metabolism, February 2016, Elsevier

    Mr Myrl D. Holida

  7. Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase

    Article • PLoS ONE, August 2015, PLOS

    M.D. DANIEL G BICHET, Mr Myrl D. Holida

  8. Recommendation for initiation and cessation of enzyme replacement therapy

    Article • Drug Design Development and Therapy, July 2015, Dove Medical Press

    Mr Myrl D. Holida, Dr Reena Sharma, Professor JACEK MUSIAL, Dr Bojan Vujkovac

  9. Comparison of clinical practice guidelines and actual clinical practice in Fabry disease diagnosis

    Article • Molecular Genetics and Metabolism, February 2015, Elsevier

    Mr Myrl D. Holida

  10. A phase 2a study to investigate the effect of a single dose of migalastat HCl, a pharmacological chaperone, on agalsidase activity in subjects with Fabry disease

    Article • Molecular Genetics and Metabolism, February 2013, Elsevier

    Mr Myrl D. Holida, M.D. DANIEL G BICHET

  11. Transplantation - clinical I

    Article • Nephrology Dialysis Transplantation, May 2012, Oxford University Press (OUP)

    Mr Myrl D. Holida

  12. 45. Myocardial infiltration in Anderson–Fabry disease: A case report

    Article • Molecular Genetics and Metabolism, February 2008, Elsevier

    Mr Myrl D. Holida

  13. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation

    Article • British Journal of Pharmacology, August 2003, Springer Science + Business Media

    Mr Myrl D. Holida

  14. Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman–Diamond syndrome

    Article • British Journal of Pharmacology, January 2002, Springer Science + Business Media

    Mr Myrl D. Holida

  15. Epstein Barr virus associated lymphoproliferative disease following T-cell depleted pediatric bone marrow transplantation, retrospective analysis of potential risk factors at a single institute

    Article • July 2000, Wolters Kluwer Health

    Mr Myrl D. Holida

  16. Poor outcome in children with refractory/relapsed leukemia undergoing bone marrow transplantation with mismatched family member donors

    Article • British Journal of Pharmacology, April 2000, Springer Science + Business Media

    Mr Myrl D. Holida

  17. Ten‐year experience of unrelated bone marrow donor transplants in children with malignant and non‐malignant conditions

    Article • Pediatric Transplantation, February 1999, Wiley

    Mr Myrl D. Holida

  18. #679 Bone marrow transplantation using mismatched, Dr-identical, or matched family member donors for children with refractory or relapsed leukemia

    Article • Journal of Pediatric Hematology/Oncology, July 1998, Wolters Kluwer Health

    Mr Myrl D. Holida

  19. Complete heart block in association with graft-versus-host disease

    Article • British Journal of Pharmacology, January 1998, Springer Science + Business Media

    Mr Myrl D. Holida

  20. Successful program to prevent aspergillus infections in children undergoing marrow transplantation: use of nasal amphotericin

    Article • British Journal of Pharmacology, January 1997, Springer Science + Business Media

    Mr Myrl D. Holida

  21. Bone Marrow Transplantation Improves Survival for Acute Lymphoblastic Leukemia in Relapse: A Preliminary Report

    Article • Journal of Pediatric Hematology/Oncology, January 1990, Wolters Kluwer Health

    Mr Myrl D. Holida

  22. INFECTIOUS COMPLICATIONS FOLLOWING MISMATCHED VERSUS MATCHED ALLOGENEIC BONE MARROW TRANSPLANTATION (BMT)

    Article • Journal of Pediatric Hematology/Oncology, January 1990, Wolters Kluwer Health

    Mr Myrl D. Holida

  23. 23. IMPROVED SURVIVAL IN RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA WITH BONE MARROW TRANSPLANTATION

    Article • Journal of Pediatric Hematology/Oncology, January 1990, Wolters Kluwer Health

    Mr Myrl D. Holida

  24. Prostaglandin E1 Bladder Instillations to Control Severe Hemorrhagic Cystitis

    Article • The Journal of Urology, January 1990, Elsevier

    Mr Myrl D. Holida

  25. Effects of acute atrial fibrillation on the vasodilator reserve of the canine atrium

    Article • Cardiovascular Research, September 1986, European Society of Cardiology

    Mr Myrl D. Holida

  26. Quantitative angiographic morphology of coronary stenoses leading to myocardial infarction or unstable angina

    Article • Circulation, February 1986, Wolters Kluwer Health

    Mr Myrl D. Holida

  27. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man

    Article • Circulation, July 1985, Wolters Kluwer Health

    Mr Myrl D. Holida